Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
11 drugs in development
By Therapeutic Area
top 5
R&D Momentum
86/100
Pipeline Velocity
64/100
Trial Completion Rate
71/100
Pipeline Concentration
44/100
Pipeline Freshness
56/100
Strategic Signals
Activity
Last 14 days
Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis
Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
Road to Discovery for Combination Probiotic BB-12 With LGG (Different Doses) in Treating Autism Spectrum Disorder Disorders
Threat-related Sensory Cortical (SC) Disinhibition and SPA Pathology in Posttraumatic Stress Disorder (PTSD) (Aim 3; Expts. 2&3)
Dynamic Effect of Occlusal Vertical Dimension on Lower Facial Form and Lip Positions
Humidity in Incubators for Tiny Infants (HumidITI) Trial
A Randomized Control Trial of Transcutaneous Tibial Nerve Stimulation for Neurogenic Bladder in the Pediatric Population
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)